Literature DB >> 12480919

Mitochondria-mediated apoptosis of lung epithelial cells in idiopathic interstitial pneumonias.

Kazuyoshi Kuwano1, Naoki Hagimoto, Takashige Maeyama, Masaki Fujita, Michihiro Yoshimi, Ichiro Inoshima, Nobutaka Nakashima, Naoki Hamada, Kentaro Watanabe, Nobuyuki Hara.   

Abstract

We previously demonstrated that the up-regulation of p53, Fas, and DNA damage are present in lung epithelial cells from patients with idiopathic interstitial pneumonias (IIP). Fas ligation induces apoptosis of lung epithelial cells predominantly through the direct activation of the caspase cascade via caspase-8 activation, whereas the up-regulation of p53 and other cellular stresses can induce mitochondria-mediated apoptosis. In this study, we investigated the incidence of mitochondria-mediated apoptosis of epithelial cells in IIP. We performed TUNEL staining to detect apoptotic cells and western blot analysis and immunohistochemistry to assess the expression and activation of caspases and the cytochrome c release from mitochondria in lung tissues from eight patients with usual interstitial pneumonia, five patients with nonspecific interstitial pneumonia, and eight patients with normal lung parenchyma. The expressions of pro- and cleaved caspase-8, 9, 3, and cytochrome c release from the mitochondria were all significantly increased in the lung tissues of IIP compared with normal lung parenchyma. The positive signals for caspases in epithelial cells were increased in IIP compared with normal lung parenchyma by immunohistochemistry. The results of TUNEL and electron microscopy suggested that apoptotic cells were predominantly epithelial cells. TUNEL-positive cells in % of epithelial cells were significantly increased in IIP compared with normal lung parenchyma, and significantly correlated with cytochrome c release from the mitochondria and with the expression of cleaved caspase-3 in epithelial cells. We conclude that mitochondria-mediated apoptosis may be involved in the pathophysiology of IIP.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12480919     DOI: 10.1097/01.lab.0000045084.81853.76

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  21 in total

1.  The p53-Mdm2 association in epithelial cells in idiopathic pulmonary fibrosis and non-specific interstitial pneumonia.

Authors:  N Nakashima; K Kuwano; T Maeyama; N Hagimoto; M Yoshimi; N Hamada; M Yamada; Y Nakanishi
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

2.  Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors.

Authors:  Masahiro Tsuboi; Thierry Le Chevalier
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

3.  Doxycycline attenuated pulmonary fibrosis induced by bleomycin in mice.

Authors:  Masaki Fujita; Qing Ye; Hiroshi Ouchi; Eiji Harada; Ichiro Inoshima; Kazuyoshi Kuwano; Yoichi Nakanishi
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

Review 4.  Evolving concepts of apoptosis in idiopathic pulmonary fibrosis.

Authors:  Victor J Thannickal; Jeffrey C Horowitz
Journal:  Proc Am Thorac Soc       Date:  2006-06

5.  Hypermethylation-mediated silencing of p14(ARF) in fibroblasts from idiopathic pulmonary fibrosis.

Authors:  José Cisneros; James Hagood; Marco Checa; Blanca Ortiz-Quintero; Miguel Negreros; Iliana Herrera; Carlos Ramos; Annie Pardo; Moisés Selman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-06-15       Impact factor: 5.464

Review 6.  Targeting NOX enzymes in pulmonary fibrosis.

Authors:  Louise Hecker; Jeff Cheng; Victor J Thannickal
Journal:  Cell Mol Life Sci       Date:  2012-05-23       Impact factor: 9.261

7.  Oxidative Modifications of Protein Tyrosyl Residues Are Increased in Plasma of Human Subjects with Interstitial Lung Disease.

Authors:  Subramaniam Pennathur; Anuradha Vivekanandan-Giri; Morgan L Locy; Tejaswini Kulkarni; Degui Zhi; Lixia Zeng; Jaeman Byun; Joao A de Andrade; Victor J Thannickal
Journal:  Am J Respir Crit Care Med       Date:  2016-04-15       Impact factor: 21.405

8.  WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis.

Authors:  Melanie Königshoff; Monika Kramer; Nisha Balsara; Jochen Wilhelm; Oana Veronica Amarie; Andreas Jahn; Frank Rose; Ludger Fink; Werner Seeger; Liliana Schaefer; Andreas Günther; Oliver Eickelberg
Journal:  J Clin Invest       Date:  2009-03-16       Impact factor: 14.808

9.  Protective effect of geranylgeranylacetone, an inducer of heat shock protein 70, against drug-induced lung injury/fibrosis in an animal model.

Authors:  Takayoshi Fujibayashi; Naozumi Hashimoto; Mayumi Jijiwa; Yoshinori Hasegawa; Toshihisa Kojima; Naoki Ishiguro
Journal:  BMC Pulm Med       Date:  2009-09-16       Impact factor: 3.317

Review 10.  Understanding the mechanisms of drug-associated interstitial lung disease.

Authors:  T Higenbottam; K Kuwano; B Nemery; Y Fujita
Journal:  Br J Cancer       Date:  2004-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.